Cizzle Biotechnology Holdings PLC (GB:CIZ) has released an update.
Cizzle Biotechnology Holdings PLC, a UK diagnostics developer, has released its Annual Report and Financial Statements for the fiscal year ending December 31, 2023. The report is accessible online and details the company’s progress on developing an early detection blood test for lung cancer, leveraging a biomarker associated with early-stage disease. Investors and the public can stay informed through the company’s website and social media channels.
For further insights into GB:CIZ stock, check out TipRanks’ Stock Analysis page.
